There's A Reason Zika Virus Became A Pandemic In 2015 according to : The Huffington Post

These mosquitos, which also transmit West Nile virus, dengue fever and chikungunya, are highly adapted to human environments. West Nile virus cycles between horses and birds and can be passed on to human beings via mosquitos that have bitten infected animals. In the case of the Zika virus epidemic, scientists suspect that rising global temperatures contributed to the spread of the Aedes aegypti mosquito that transmits the disease. In addition to mosquito-friendly climates, human beings' globetrotting travel patterns also give viruses a boost. Paull found that drought conditions increase transmission of the virus from mosquitos to human beings, for reasons that are still unclear.




Zika Virus Infections – Pipeline Review, H2 2016, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape. The Zika Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Zika Virus Infections and features dormant and discontinued projects. – The pipeline guide reviews latest news related to pipeline therapeutics for Zika Virus Infections (Infectious Disease)Browse the full report @ http://www.orbisresearch.com/reports/index/zika-virus-infections-pipeline-review-h2-2016 . – Formulate corrective measures for pipeline projects by understanding Zika Virus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics. Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes.

Novel mRNA Zika Virus Vaccine Shows Rapid and Durable Protection

Novel mRNA Zika Virus Vaccine Shows Rapid and Durable ProtectionShare this content:linkedingoogleEmailPrintA novel messenger RNA Zika vaccine showed strong and stable antiviral responses in preliminary studies in mice and rhesus monkeys. The vaccine was next studied in rhesus macaque monkeys and demonstrated similar responses to the Zika virus compared with humans. No significant differences were observed across doses in rhesus monkeys given prM-E mRNA-LMP anti-ZIKV vaccine 600 μg, 200 μg, or 50 μg and no adverse effects were noted. Rapid outbreaks over the past 2 years in 70 countries3 have indicated the need for a vaccine that is safe and can produce sufficient viral protection after a single immunization. The IgG titers in monkeys reached >300,000 in all groups at week 4, with levels of ≥100,000 sustained until week 12.


collected by :Sandra Alex
To follow all the new news about

VIRUSES and INFECTIONS